| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $21.14M | $19.89M | $15.31M | $13.03M | $2.29M |
| R&D | $13.45M | $11.05M | $6.80M | $5.68M | $255.00K |
| SG&A | $7.69M | $8.84M | $8.52M | $7.35M | $2.03M |
| Operating Income | -$21.14M | -$19.89M | -$15.31M | -$13.03M | -$2.29M |
| Interest Expense | – | – | – | – | $2.17M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$21.02M | -$19.45M | -$14.64M | -$12.96M | -$4.43M |
| EPS (basic) | -0.6200 | -0.7300 | -0.7200 | -1.5900 | -1.0300 |
| EPS (diluted) | -0.6200 | -0.7300 | -0.7200 | -1.5900 | -1.0300 |
| Shares (diluted) | $33.71M | $26.65M | $20.33M | $8.17M | $4.28M |